{
  "DOI": "10.1038/s41431-021-00981-z",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-021-00981-z",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eThis single-center study aims to determine the time, diagnostic procedure, and cost saving potential of early exome sequencing in a cohort of 111 individuals with genetically confirmed neurodevelopmental disorders. We retrospectively collected data regarding diagnostic time points and procedures from the individuals’ medical histories and developed criteria for classifying diagnostic procedures in terms of requirement, followed by a cost allocation. All genetic variants were re-evaluated according to ACMG recommendations and considering the individuals’ phenotype. Individuals who developed first symptoms of their underlying genetic disorder when Next Generation Sequencing (NGS) diagnostics were already available received a diagnosis significantly faster than individuals with first symptoms before this cutoff. The largest amount of potentially dispensable diagnostics was found in genetic, metabolic, and cranial magnetic resonance imaging examinations. Out of 407 performed genetic examinations, 296 (72.7%) were classified as potentially dispensable. The same applied to 36 (27.9%) of 129 cranial magnetic resonance imaging and 111 (31.8%) of 349 metabolic examinations. Dispensable genetic examinations accounted 302,947.07€ (90.2%) of the total 335,837.49€ in potentially savable costs in this cohort. The remaining 32,890.42€ (9.8%) are related to non-required metabolic and cranial magnetic resonance imaging diagnostics. On average, the total potentially savable costs in our study amount to €3,025.56 per individual. Cost savings by first tier exome sequencing lie primarily in genetic, metabolic, and cMRI testing in this German cohort, underscoring the utility of performing exome sequencing at the beginning of the diagnostic pathway and the potential for saving diagnostic costs and time.\u003c/jats:p\u003e",
  "alternative-id": [
    "981"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "15 June 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "22 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "4 October 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "25 October 2021"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The project was approved by the ethic committee of the University of Leipzig, Germany (224/16-ek and 402/16-ek) and was conducted in concordance to the declaration of Helsinki. Individuals or their parents or legal guardians consented to genetic testing."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Klau",
      "given": "Julia",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1542-1399",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Abou Jamra",
      "given": "Rami",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Radtke",
      "given": "Maximilian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Oppermann",
      "given": "Henry",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-4435-6610",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Lemke",
      "given": "Johannes R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Beblo",
      "given": "Skadi",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3679-1081",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Popp",
      "given": "Bernt",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        10,
        25
      ]
    ],
    "date-time": "2021-10-25T01:02:23Z",
    "timestamp": 1635123743000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        1,
        7
      ]
    ],
    "date-time": "2022-01-07T00:19:22Z",
    "timestamp": 1641514762000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001659",
      "award": [
        "grant PO2366/2–1"
      ],
      "doi-asserted-by": "publisher",
      "name": "Deutsche Forschungsgemeinschaft"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ],
    "date-time": "2024-04-24T05:56:53Z",
    "timestamp": 1713938213879
  },
  "is-referenced-by-count": 22,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        10,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2022,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            25
          ]
        ],
        "date-time": "2021-10-25T00:00:00Z",
        "timestamp": 1635120000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            25
          ]
        ],
        "date-time": "2021-10-25T00:00:00Z",
        "timestamp": 1635120000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-021-00981-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00981-z",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00981-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "117-125",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2021,
        10,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        10,
        25
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.4065/76.8.777",
      "author": "P Kumar",
      "doi-asserted-by": "publisher",
      "first-page": "777",
      "journal-title": "Mayo Clin Proc",
      "key": "981_CR1",
      "unstructured": "Kumar P, Radhakrishnan J, Chowdhary MA, Giampietro PF. Prevalence and Patterns of Presentation of Genetic Disorders in a Pediatric Emergency Department. Mayo Clin Proc. 2001;76:777–83. https://doi.org/10.4065/76.8.777",
      "volume": "76",
      "year": "2001"
    },
    {
      "DOI": "10.1001/archpedi.1997.02170480026004",
      "author": "PW Yoon",
      "doi-asserted-by": "publisher",
      "first-page": "1096",
      "journal-title": "Arch Pediatr Adolesc Med",
      "key": "981_CR2",
      "unstructured": "Yoon PW. Contribution of Birth Defects and Genetic Diseases to Pediatric Hospitalizations: a Population-Based Study. Arch Pediatr Adolesc Med. 1997;151:1096 https://doi.org/10.1001/archpedi.1997.02170480026004",
      "volume": "151",
      "year": "1997"
    },
    {
      "DOI": "10.1038/nature13394",
      "author": "C Gilissen",
      "doi-asserted-by": "publisher",
      "first-page": "344",
      "journal-title": "Nature",
      "key": "981_CR3",
      "unstructured": "Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BWM, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344–7. https://doi.org/10.1038/nature13394",
      "volume": "511",
      "year": "2014"
    },
    {
      "DOI": "10.1542/peds.2016-3908",
      "author": "KM Aaberg",
      "doi-asserted-by": "publisher",
      "first-page": "e20163908",
      "journal-title": "Pediatrics",
      "key": "981_CR4",
      "unstructured": "Aaberg KM, Gunnes N, Bakken IJ, Lund Søraas C, Berntsen A, Magnus P, et al. Incidence and Prevalence of Childhood Epilepsy: a Nationwide Cohort Study. Pediatrics. 2017;139:e20163908 https://doi.org/10.1542/peds.2016-3908",
      "volume": "139",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.seizure.2016.11.030",
      "author": "J Wang",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Seizure",
      "key": "981_CR5",
      "unstructured": "Wang J, Lin Z-J, Liu L, Xu H-Q, Shi Y-W, Yi Y-H, et al. Epilepsy-associated genes. Seizure. 2017;44:11–20. https://doi.org/10.1016/j.seizure.2016.11.030",
      "volume": "44",
      "year": "2017"
    },
    {
      "DOI": "10.1111/cge.13882",
      "author": "C Hanly",
      "doi-asserted-by": "publisher",
      "first-page": "335",
      "journal-title": "Clin Genet",
      "key": "981_CR6",
      "unstructured": "Hanly C, Shah H, Au PYB, Murias K. Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: a scoping review. Clin Genet. 2021;99:335–46. https://doi.org/10.1111/cge.13882",
      "volume": "99",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s10897-014-9773-9",
      "author": "N Carmichael",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "journal-title": "J Genet Couns",
      "key": "981_CR7",
      "unstructured": "Carmichael N, Tsipis J, Windmueller G, Mandel L, Estrella E. “Is it Going to Hurt?”: the Impact of the Diagnostic Odyssey on Children and Their Families. J Genet Couns. 2015;24:325–35. https://doi.org/10.1007/s10897-014-9773-9",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41436-018-0398-5",
      "author": "N Gonzaludo",
      "doi-asserted-by": "publisher",
      "first-page": "1781",
      "journal-title": "Genet Med",
      "key": "981_CR8",
      "unstructured": "Gonzaludo N, Belmont JW, Gainullin VG, Taft RJ. Estimating the burden and economic impact of pediatric genetic disease. Genet Med. 2019;21:1781–9. https://doi.org/10.1038/s41436-018-0398-5",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1086/381053",
      "author": "SE McCandless",
      "doi-asserted-by": "publisher",
      "first-page": "121",
      "journal-title": "Am J Hum Genet",
      "key": "981_CR9",
      "unstructured": "McCandless SE, Brunger JW, Cassidy SB. The Burden of Genetic Disease on Inpatient Care in a Children’s Hospital. Am J Hum Genet. 2004;74:121–7. https://doi.org/10.1086/381053",
      "volume": "74",
      "year": "2004"
    },
    {
      "DOI": "10.1111/dmcn.13557",
      "author": "RG Arim",
      "doi-asserted-by": "publisher",
      "first-page": "1284",
      "journal-title": "Dev Med Child Neurol",
      "key": "981_CR10",
      "unstructured": "Arim RG, Miller AR, Guèvremont A, Lach LM, Brehaut JC, Kohen DE. Children with neurodevelopmental disorders and disabilities: a population-based study of healthcare service utilization using administrative data. Dev Med Child Neurol. 2017;59:1284–90. https://doi.org/10.1111/dmcn.13557",
      "volume": "59",
      "year": "2017"
    },
    {
      "DOI": "10.2165/00019053-200826060-00002",
      "author": "A Strzelczyk",
      "doi-asserted-by": "publisher",
      "first-page": "463",
      "journal-title": "PharmacoEconomics",
      "key": "981_CR11",
      "unstructured": "Strzelczyk A, Reese JP, Dodel R, Hamer HM. Cost of epilepsy: a systematic review. PharmacoEconomics. 2008;26:463–76. https://doi.org/10.2165/00019053-200826060-00002",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1038/s41436-019-0534-x",
      "author": "D Schofield",
      "doi-asserted-by": "publisher",
      "first-page": "2586",
      "journal-title": "Genet Med",
      "key": "981_CR12",
      "unstructured": "Schofield D, Rynehart L, Shresthra R, White SM, Stark Z. Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes. Genet Med. 2019;21:2586–93. https://doi.org/10.1038/s41436-019-0534-x",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1126/scitranslmed.3003544",
      "author": "TJ Dixon-Salazar",
      "doi-asserted-by": "publisher",
      "first-page": "138ra78",
      "journal-title": "Sci Transl Med",
      "key": "981_CR13",
      "unstructured": "Dixon-Salazar TJ, Silhavy JL, Udpa N, Schroth J, Bielas S, Schaffer AE, et al. Exome Sequencing Can Improve Diagnosis and Alter Patient Management. Sci Transl Med. 2012;4:138ra78–138ra78. https://doi.org/10.1126/scitranslmed.3003544",
      "volume": "4",
      "year": "2012"
    },
    {
      "DOI": "10.1111/j.1365-2214.2006.00666.x",
      "author": "AH Graungaard",
      "doi-asserted-by": "publisher",
      "first-page": "296",
      "journal-title": "Child Care Health Dev",
      "key": "981_CR14",
      "unstructured": "Graungaard AH, Skov L. Why do we need a diagnosis? A qualitative study of parents? experiences, coping and needs, when the newborn child is severely disabled. Child Care Health Dev. 2007;33:296–307. https://doi.org/10.1111/j.1365-2214.2006.00666.x",
      "volume": "33",
      "year": "2007"
    },
    {
      "DOI": "10.1038/gim.2014.58",
      "author": "A Iglesias",
      "doi-asserted-by": "publisher",
      "first-page": "922",
      "journal-title": "Genet Med",
      "key": "981_CR15",
      "unstructured": "Iglesias A, Anyane-Yeboa K, Wynn J, Wilson A, Truitt Cho M, Guzman E, et al. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med. 2014;16:922–31. https://doi.org/10.1038/gim.2014.58",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1002/ana.24251",
      "author": "S Srivastava",
      "doi-asserted-by": "publisher",
      "first-page": "473",
      "journal-title": "Ann Neurol",
      "key": "981_CR16",
      "unstructured": "Srivastava S, Cohen JS, Vernon H, Barañano K, McClellan R, Jamal L, et al. Clinical whole exome sequencing in child neurology practice: WES in Child Neurology. Ann Neurol. 2014;76:473–83. https://doi.org/10.1002/ana.24251",
      "volume": "76",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s12920-016-0167-8",
      "author": "P Rump",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Med Genom",
      "key": "981_CR17",
      "unstructured": "Rump P, Jazayeri O, van Dijk-Bos KK, Johansson LF, van Essen AJ, Verheij JBGM, et al. Whole-exome sequencing is a powerful approach for establishing the etiological diagnosis in patients with intellectual disability and microcephaly. BMC Med Genom. 2015;9:7 https://doi.org/10.1186/s12920-016-0167-8",
      "volume": "9",
      "year": "2015"
    },
    {
      "DOI": "10.2174/0929867324666170718101946",
      "author": "A Fernandez-Marmiesse",
      "doi-asserted-by": "publisher",
      "first-page": "404",
      "journal-title": "CMC",
      "key": "981_CR18",
      "unstructured": "Fernandez-Marmiesse A, Gouveia S, Couce ML. NGS Technologies as a Turning Point in Rare Disease Research, Diagnosis and Treatment. CMC. 2018;25:404–32. https://doi.org/10.2174/0929867324666170718101946",
      "volume": "25",
      "year": "2018"
    },
    {
      "DOI": "10.3389/fneur.2019.00434",
      "author": "M Demos",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "journal-title": "Front Neurol",
      "key": "981_CR19",
      "unstructured": "Demos M, Guella I, DeGuzman C, McKenzie MB, Buerki SE, Evans DM, et al. Diagnostic Yield and Treatment Impact of Targeted Exome Sequencing in Early-Onset Epilepsy. Front Neurol. 2019;10:434 https://doi.org/10.3389/fneur.2019.00434",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41431-018-0203-6",
      "author": "T Vrijenhoek",
      "doi-asserted-by": "publisher",
      "first-page": "1566",
      "journal-title": "Eur J Hum Genet",
      "key": "981_CR20",
      "unstructured": "Vrijenhoek T, Middelburg EM, Monroe GR, van Gassen KLI, Geenen JW, Hövels AM, et al. Whole-exome sequencing in intellectual disability; cost before and after a diagnosis. Eur J Hum Genet. 2018;26:1566–71. https://doi.org/10.1038/s41431-018-0203-6",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41431-018-0099-1",
      "author": "OJ Dillon",
      "doi-asserted-by": "publisher",
      "first-page": "644",
      "journal-title": "Eur J Hum Genet",
      "key": "981_CR21",
      "unstructured": "Dillon OJ, Lunke S, Stark Z, Yeung A, Thorne N, Gaff C, et al. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders. Eur J Hum Genet. 2018;26:644–51. https://doi.org/10.1038/s41431-018-0099-1",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41436-021-01153-6",
      "doi-asserted-by": "publisher",
      "key": "981_CR22",
      "unstructured": "Zacher P, Mayer T, Brandhoff F, Bartolomaeus T, Le Duc D, Finzel M, et al. The genetic landscape of intellectual disability and epilepsy in adults and the elderly: a systematic genetic work-up of 150 individuals. Genet Med. 2021. https://doi.org/10.1038/s41436-021-01153-6."
    },
    {
      "DOI": "10.1001/jamapediatrics.2017.1970",
      "author": "JR Lemke",
      "doi-asserted-by": "publisher",
      "first-page": "833",
      "journal-title": "JAMA Pediatr",
      "key": "981_CR23",
      "unstructured": "Lemke JR. High-Throughput Sequencing as First-Tier Diagnostics in Congenital and Early-Onset Disorders. JAMA Pediatr. 2017;171:833 https://doi.org/10.1001/jamapediatrics.2017.1970",
      "volume": "171",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41436-019-0554-6",
      "author": "S Srivastava",
      "doi-asserted-by": "publisher",
      "first-page": "2413",
      "journal-title": "Genet Med",
      "key": "981_CR24",
      "unstructured": "Srivastava S, Love-Nichols JA, Dies KA, Ledbetter DH, Martin CL, Chung WK, et al. Meta-analysis and multidisciplinary consensus statement: exomesequencing is a first-tier clinical diagnostic test for individuals withneurodevelopmental disorders. Genet Med. 2019;21:2413–21. https://doi.org/10.1038/s41436-019-0554-6",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.ajhg.2015.11.024",
      "author": "K Kochinke",
      "doi-asserted-by": "publisher",
      "first-page": "149",
      "journal-title": "Am J Hum Genet",
      "key": "981_CR25",
      "unstructured": "Kochinke K, Zweier C, Nijhof B, Fenckova M, Cizek P, Honti F, et al. Systematic Phenomics Analysis Deconvolutes Genes Mutated in Intellectual Disability into Biologically Coherent Modules. Am J Hum Genet. 2016;98:149–64. https://doi.org/10.1016/j.ajhg.2015.11.024",
      "volume": "98",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2016.221",
      "author": "Z Stark",
      "doi-asserted-by": "publisher",
      "first-page": "867",
      "journal-title": "Genet Med",
      "key": "981_CR26",
      "unstructured": "Stark Z, Schofield D, Alam K, Wilson W, Mupfeki N, Macciocca I, et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med. 2017;19:867–74. https://doi.org/10.1038/gim.2016.221",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jamapediatrics.2017.1755",
      "author": "TY Tan",
      "doi-asserted-by": "publisher",
      "first-page": "855",
      "journal-title": "JAMA Pediatr",
      "key": "981_CR27",
      "unstructured": "Tan TY, Dillon OJ, Stark Z, Schofield D, Alam K, Shrestha R, et al. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions. JAMA Pediatr. 2017;171:855 https://doi.org/10.1001/jamapediatrics.2017.1755",
      "volume": "171",
      "year": "2017"
    },
    {
      "DOI": "10.1126/scitranslmed.3010076",
      "author": "SE Soden",
      "doi-asserted-by": "publisher",
      "first-page": "265ra168",
      "journal-title": "Sci Transl Med",
      "key": "981_CR28",
      "unstructured": "Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014;6:265ra168–265ra168. https://doi.org/10.1126/scitranslmed.3010076",
      "volume": "6",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2016.1",
      "author": "Z Stark",
      "doi-asserted-by": "publisher",
      "first-page": "1090",
      "journal-title": "Genet Med",
      "key": "981_CR29",
      "unstructured": "Stark Z, Tan TY, Chong B, Brett GR, Yap P, Walsh M, et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet Med. 2016;18:1090–6. https://doi.org/10.1038/gim.2016.1",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41431-020-0672-2",
      "author": "O Quenez",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "journal-title": "Eur J Hum Genet",
      "key": "981_CR30",
      "unstructured": "Quenez O, Cassinari K, Coutant S, Lecoquierre F, Le Guennec K, Rousseau S, et al. Detection of copy-number variations from NGS data using read depth information: a diagnostic performance evaluation. Eur J Hum Genet. 2021;29:99–109. https://doi.org/10.1038/s41431-020-0672-2",
      "volume": "29",
      "year": "2021"
    },
    {
      "DOI": "10.1001/jamapediatrics.2017.1743",
      "author": "AT Berg",
      "doi-asserted-by": "publisher",
      "first-page": "863",
      "journal-title": "JAMA Pediatr",
      "key": "981_CR31",
      "unstructured": "Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, et al. Early-Life Epilepsies and the Emerging Role of Genetic Testing. JAMA Pediatr. 2017;171:863 https://doi.org/10.1001/jamapediatrics.2017.1743",
      "volume": "171",
      "year": "2017"
    },
    {
      "DOI": "10.1038/jhg.2014.124",
      "author": "S Miyatake",
      "doi-asserted-by": "publisher",
      "first-page": "175",
      "journal-title": "J Hum Genet",
      "key": "981_CR32",
      "unstructured": "Miyatake S, Koshimizu E, Fujita A, Fukai R, Imagawa E, Ohba C, et al. Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: an ‘exome-first’ approach. J Hum Genet. 2015;60:175–82. https://doi.org/10.1038/jhg.2014.124",
      "volume": "60",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0156359",
      "author": "D Yubero",
      "doi-asserted-by": "publisher",
      "first-page": "e0156359",
      "journal-title": "PLoS ONE",
      "key": "981_CR33",
      "unstructured": "Yubero D, Brandi N, Ormazabal A, Garcia-Cazorla À, Pérez-Dueñas B, Campistol J, et al. Targeted Next Generation Sequencing in Patients with Inborn Errors of Metabolism. PLoS ONE. 2016;11:e0156359 https://doi.org/10.1371/journal.pone.0156359",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2015.200",
      "author": "GR Monroe",
      "doi-asserted-by": "publisher",
      "first-page": "949",
      "journal-title": "Genet Med",
      "key": "981_CR34",
      "unstructured": "Monroe GR, Frederix GW, Savelberg SMC, de Vries TI, Duran KJ, van der Smagt JJ, et al. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability. Genet Med. 2016;18:949–56. https://doi.org/10.1038/gim.2015.200",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.lanwpc.2020.100001",
      "author": "CCY Chung",
      "doi-asserted-by": "publisher",
      "first-page": "100001",
      "journal-title": "Lancet Regional Health - West Pac",
      "key": "981_CR35",
      "unstructured": "Chung CCY, Leung GKC, Mak CCY, Fung JLF, Lee M, Pei SLC, et al. Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs. Lancet Regional Health - West Pac. 2020;1:100001 https://doi.org/10.1016/j.lanwpc.2020.100001",
      "volume": "1",
      "year": "2020"
    },
    {
      "DOI": "10.1111/jspn.12150",
      "author": "B Seliner",
      "doi-asserted-by": "publisher",
      "first-page": "147",
      "journal-title": "J Spec Pediatr Nurs",
      "key": "981_CR36",
      "unstructured": "Seliner B, Latal B, Spirig R. When children with profound multiple disabilities are hospitalized: A cross-sectional survey of parental burden of care, quality of life of parents and their hospitalized children, and satisfaction with family-centered care: Parents of hospitalized children with disabilities. J Spec Pediatr Nurs. 2016;21:147–57. https://doi.org/10.1111/jspn.12150",
      "volume": "21",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s11547-018-0896-1",
      "author": "S Salerno",
      "doi-asserted-by": "publisher",
      "first-page": "695",
      "journal-title": "Radio Med",
      "key": "981_CR37",
      "unstructured": "Salerno S, Granata C, Trapenese M, Cannata V, Curione D, Rossi Espagnet MC, et al. Is MRI imaging in pediatric age totally safe? A critical reprisal. Radio Med. 2018;123:695–702. https://doi.org/10.1007/s11547-018-0896-1",
      "volume": "123",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.braindev.2017.04.006",
      "author": "K Murias",
      "doi-asserted-by": "publisher",
      "first-page": "644",
      "journal-title": "Brain Dev",
      "key": "981_CR38",
      "unstructured": "Murias K, Moir A, Myers KA, Liu I, Wei X-C. Systematic review of MRI findings in children with developmental delay or cognitive impairment. Brain Dev. 2017;39:644–55. https://doi.org/10.1016/j.braindev.2017.04.006",
      "volume": "39",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41525-020-00144-x",
      "author": "JLF Fung",
      "doi-asserted-by": "publisher",
      "first-page": "37",
      "journal-title": "Npj Genom Med",
      "key": "981_CR39",
      "unstructured": "Fung JLF, Yu MHC, Huang S, Chung CCY, Chan MCY, Pajusalu S, et al. A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis. Npj Genom Med. 2020;5:37 https://doi.org/10.1038/s41525-020-00144-x",
      "volume": "5",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.gene.2019.03.037",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "first-page": "168",
      "journal-title": "Gene",
      "key": "981_CR40",
      "unstructured": "Li J, Gao K, Yan H, Xiangwei W, Liu N, Wang T, et al. Reanalysis of whole exome sequencing data in patients with epilepsy and intellectual disability/mental retardation. Gene. 2019;700:168–75. https://doi.org/10.1016/j.gene.2019.03.037",
      "volume": "700",
      "year": "2019"
    }
  ],
  "reference-count": 40,
  "references-count": 40,
  "relation": {
    "has-preprint": [
      {
        "asserted-by": "object",
        "id": "10.1101/2021.07.23.21258974",
        "id-type": "doi"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-021-00981-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Exome first approach to reduce diagnostic costs and time – retrospective analysis of 111 individuals with rare neurodevelopmental disorders"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "30"
}